Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Koerber

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Analytical Chemistry|November 13, 2023
High-Throughput Analyses of Therapeutic Antibodies Using High-Field Asymmetric Waveform Ion Mobility Spectrometry Combined with SampleStream and Intact Protein Mass SpectrometryRachel Liuqing Shi, Michael A Dillon, Philip D Compton, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2025
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signalingNaruhisa Ota, Christopher W Davies, Jing Kang, et al.
Scientific Reports|May 10, 2018
A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodiesRajesh Vij, Zhonghua Lin, Nancy Chiang, et al.
Nature Immunology|March 22, 2022
Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunityRosa Barreira da Silva, Ricardo M Leitao, Ximo Pechuan-Jorge, et al.
Nature Biotechnology|January 7, 2022
Conformation-locking antibodies for the discovery and characterization of KRAS inhibitorsChristopher W Davies, Angela J Oh, Rana Mroue, et al.
Science Advances|May 22, 2026
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicityYvonne T Kschonsak, Wei-Ching Liang, Joyce Chan, et al.
Mabs|December 31, 2020
Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor responseJosefa Dela Cruz Chuh, MaryAnn Go, Yvonne Chen, et al.
Nature Communications|August 5, 2023
Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumorsAlessandra Castiglioni, Yagai Yang, Katherine Williams, et al.
The Journal of Allergy and Clinical Immunology|April 29, 2022
Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthmaJanet K Jackman, Amy Stockwell, David F Choy, et al.
Science Translational Medicine|December 14, 2022
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitisJoseph Chavarria-Smith, Cecilia P C Chiu, Janet K Jackman, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Analytical Chemistry|November 13, 2023
High-Throughput Analyses of Therapeutic Antibodies Using High-Field Asymmetric Waveform Ion Mobility Spectrometry Combined with SampleStream and Intact Protein Mass SpectrometryRachel Liuqing Shi, Michael A Dillon, Philip D Compton, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2025
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signalingNaruhisa Ota, Christopher W Davies, Jing Kang, et al.
Scientific Reports|May 10, 2018
A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodiesRajesh Vij, Zhonghua Lin, Nancy Chiang, et al.
Nature Immunology|March 22, 2022
Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunityRosa Barreira da Silva, Ricardo M Leitao, Ximo Pechuan-Jorge, et al.
Nature Biotechnology|January 7, 2022
Conformation-locking antibodies for the discovery and characterization of KRAS inhibitorsChristopher W Davies, Angela J Oh, Rana Mroue, et al.
Science Advances|May 22, 2026
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicityYvonne T Kschonsak, Wei-Ching Liang, Joyce Chan, et al.
Mabs|December 31, 2020
Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor responseJosefa Dela Cruz Chuh, MaryAnn Go, Yvonne Chen, et al.
Nature Communications|August 5, 2023
Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumorsAlessandra Castiglioni, Yagai Yang, Katherine Williams, et al.
The Journal of Allergy and Clinical Immunology|April 29, 2022
Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthmaJanet K Jackman, Amy Stockwell, David F Choy, et al.
Science Translational Medicine|December 14, 2022
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitisJoseph Chavarria-Smith, Cecilia P C Chiu, Janet K Jackman, et al.
Pageof 7